These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 30514650)

  • 1. Medical decision-making in progressive supranuclear palsy: A comparison to other neurodegenerative disorders.
    Gerstenecker A; Grimsley L; Otruba B; Cowden L; Marson DC; Gerstenecker KT; Martin RC; Roberson ED
    Parkinsonism Relat Disord; 2019 Apr; 61():77-81. PubMed ID: 30514650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.
    Pillon B; Dubois B; Agid Y
    Ann N Y Acad Sci; 1991; 640():224-7. PubMed ID: 1837977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance on the dementia rating scale in Parkinson's disease with dementia and dementia with Lewy bodies: comparison with progressive supranuclear palsy and Alzheimer's disease.
    Aarsland D; Litvan I; Salmon D; Galasko D; Wentzel-Larsen T; Larsen JP
    J Neurol Neurosurg Psychiatry; 2003 Sep; 74(9):1215-20. PubMed ID: 12933921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy.
    Soliveri P; Monza D; Paridi D; Carella F; Genitrini S; Testa D; Girotti F
    J Neurol Neurosurg Psychiatry; 2000 Sep; 69(3):313-8. PubMed ID: 10945805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity and specificity of cognitive impairment in Alzheimer's, Huntington's, and Parkinson's diseases and progressive supranuclear palsy.
    Pillon B; Dubois B; Ploska A; Agid Y
    Neurology; 1991 May; 41(5):634-43. PubMed ID: 1827513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative cognitive and neuropsychiatric profiles between Parkinson's disease, multiple system atrophy and progressive supranuclear palsy.
    Santangelo G; Cuoco S; Pellecchia MT; Erro R; Barone P; Picillo M
    J Neurol; 2018 Nov; 265(11):2602-2613. PubMed ID: 30178175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical decision-making in neurodegenerative disease: mild AD and PD with cognitive impairment.
    Griffith HR; Dymek MP; Atchison P; Harrell L; Marson DC
    Neurology; 2005 Aug; 65(3):483-5. PubMed ID: 16087924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive differences between patients with progressive supranuclear palsy and Alzheimer's disease.
    Milberg W; Albert M
    J Clin Exp Neuropsychol; 1989 Oct; 11(5):605-14. PubMed ID: 2808652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating medical decision-making capacity in patients with cognitive impairment using a protocol based on linguistic features.
    Tallberg IM; Stormoen S; Almkvist O; Eriksdotter M; Sundström E
    Scand J Psychol; 2013 Oct; 54(5):386-92. PubMed ID: 23841467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Executive dysfunction is the primary cognitive impairment in progressive supranuclear palsy.
    Gerstenecker A; Mast B; Duff K; Ferman TJ; Litvan I;
    Arch Clin Neuropsychol; 2013 Mar; 28(2):104-13. PubMed ID: 23127882
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different decision deficits impair response inhibition in progressive supranuclear palsy and Parkinson's disease.
    Zhang J; Rittman T; Nombela C; Fois A; Coyle-Gilchrist I; Barker RA; Hughes LE; Rowe JB
    Brain; 2016 Jan; 139(Pt 1):161-73. PubMed ID: 26582559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric and cognitive profile of early Richardson's syndrome, Progressive Supranuclear Palsy-parkinsonism and Parkinson's disease.
    Pellicano C; Assogna F; Cellupica N; Piras F; Pierantozzi M; Stefani A; Cerroni R; Mercuri B; Caltagirone C; Pontieri FE; Spalletta G
    Parkinsonism Relat Disord; 2017 Dec; 45():50-56. PubMed ID: 29037499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy.
    Brown RG; Lacomblez L; Landwehrmeyer BG; Bak T; Uttner I; Dubois B; Agid Y; Ludolph A; Bensimon G; Payan C; Leigh NP;
    Brain; 2010 Aug; 133(Pt 8):2382-93. PubMed ID: 20576697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sex differences for cognitive decline in progressive supranuclear palsy.
    Digma LA; Litvan I; Del Ser T; Bayram E
    Parkinsonism Relat Disord; 2023 Jul; 112():105454. PubMed ID: 37301014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotypic behaviors in degenerative dementias.
    Prioni S; Fetoni V; Barocco F; Redaelli V; Falcone C; Soliveri P; Tagliavini F; Scaglioni A; Caffarra P; Concari L; Gardini S; Girotti F
    J Neurol; 2012 Nov; 259(11):2452-9. PubMed ID: 22648476
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Energization and spoken language production: Evidence from progressive supranuclear palsy.
    Barker MS; Nelson NL; O'Sullivan JD; Adam R; Robinson GA
    Neuropsychologia; 2018 Oct; 119():349-362. PubMed ID: 30195029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cognitive deficits in progressive supranuclear palsy on the Repeatable Battery for the Assessment of Neuropsychological Status.
    Duff K; McDermott D; Luong D; Randolph C; Boxer AL
    J Clin Exp Neuropsychol; 2019 Jul; 41(5):469-475. PubMed ID: 30712468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motor, cognitive and behavioral differences in MDS PSP phenotypes.
    Picillo M; Cuoco S; Tepedino MF; Cappiello A; Volpe G; Erro R; Santangelo G; Pellecchia MT; Barone P;
    J Neurol; 2019 Jul; 266(7):1727-1735. PubMed ID: 30989369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive decline on the Repeatable Battery for the Assessment of Neuropsychological Status in progressive supranuclear palsy.
    Duff K; Randolph C; Boxer AL
    Clin Neuropsychol; 2020 Apr; 34(3):529-540. PubMed ID: 31559910
    [No Abstract]   [Full Text] [Related]  

  • 20. The pattern of verbal, visuospatial and procedural learning in Richardson variant of progressive supranuclear palsy in comparison to Parkinson's disease.
    Sitek EJ; Wieczorek D; Konkel A; Dąbrowska M; Sławek J
    Psychiatr Pol; 2017 Aug; 51(4):647-659. PubMed ID: 28987055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.